Radioiodine therapy of hyperthyroidism precludes thallium-201 myocardial scintigraphy.
Clin Nucl Med
; 12(2): 110-2, 1987 Feb.
Article
em En
| MEDLINE
| ID: mdl-3829532
ABSTRACT
The authors attempted to perform Tl-201 myocardial perfusion scintigraphy in a 42-year-old man 23 and 35 days after he received 9.8 mCi of oral I-131 for documented Graves' disease. Interference from primary and scattered photons from residual thyroid I-131 made Tl-201 myocardial scintigraphy technically impossible. A series of phantom and patient studies using I-131 and Tl-201 were performed, yielding guidelines for planning Tl-201 myocardial scintigraphy following radioiodine therapy.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Radioisótopos
/
Tálio
/
Doença de Graves
/
Radioisótopos do Iodo
/
Infarto do Miocárdio
Tipo de estudo:
Guideline
Limite:
Adult
/
Humans
/
Male
Idioma:
En
Revista:
Clin Nucl Med
Ano de publicação:
1987
Tipo de documento:
Article